Clinical Trial Update: BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating BOTOX (onabotulinumtoxinA) for headache prevention in Chinese participants with chronic migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Migraine Disorders | Phase 3 | Status: WITHDRAWN